Ruslana Alper-Pinus

Title: Innovations of Ruslana Alper-Pinus in Stem Cell Research

Introduction

Ruslana Alper-Pinus is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of stem cell research, particularly in the differentiation of retinal pigment epithelial (RPE) cells. Her work has implications for regenerative medicine and the treatment of retinal diseases.

Latest Patents

Ruslana holds a patent for "Retinal pigment epithelial cells differentiated from embryonic stem cells with nicotinamide and activin A." This invention focuses on RPE cells that can be obtained through directed differentiation from human stem cells. The process involves culturing stem cells in the presence of members of the TGFβ superfamily, such as Activin A, which induces the differentiation into mature and functional RPE cells. The effectiveness of this method is evidenced by the expression of specific markers associated with mature RPE cells, including MiTF-A, RPE65, and Bestrophin. Additionally, the use of nicotinamide has been shown to enhance the cells' response to the inductive effects of the TGFβ superfamily.

Career Highlights

Ruslana is affiliated with Hadasit Medical Research Services and Development Ltd., where she continues her research and development efforts. Her innovative work in stem cell differentiation has positioned her as a key figure in the field, contributing to advancements in medical science.

Collaborations

Ruslana collaborates with talented individuals such as Masha Idelson and Alex Obolensky. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Ruslana Alper-Pinus is a pioneering inventor whose work in stem cell research is paving the way for new treatments in regenerative medicine. Her patent on RPE cell differentiation showcases her commitment to advancing medical science and improving patient outcomes.